Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

3M Q4 EPS $2.31 Beats $2.01 Estimate, Sales $8.60B Beat $8.59B Estimate

3M (NYSE:MMM) reported quarterly earnings of $2.31 per share which beat the analyst consensus estimate of $2.01 by 14.93 percent. This is a 2.94 percent decrease over earnings of $2.38 per share from the same period last
byBill Haddad
January 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

3M (NYSE:MMM) reported quarterly earnings of $2.31 per share which beat the analyst consensus estimate of $2.01 by 14.93 percent. This is a 2.94 percent decrease over earnings of $2.38 per share from the same period last year. The company reported quarterly sales of $8.60 billion which beat the analyst consensus estimate of $8.59 billion by 0.12 percent. This is a 0.20 percent increase over sales of $8.58 billion the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AstraZeneca Announced Nirsevimab Showed 74.5% Efficacy Against Medically Attended Lower Respiratory Tract Infections Caused by Respiratory Syncytial Virus in Healthy Infants

By Charles Gross
Today, 5:44 AM
Detailed results from the positive MELODY Phase III trial showed a single dose of AstraZeneca and Sanofi's nirsevimab met the primary efficacy endpoint reducing the incidence of medically attended lower respiratory tract infections (LRTI) caused by respiratory syncytial virus (RSV) by 74.5% (95% CI 49.6, 87.1; p<0.001), compared to placebo.1-2

AZN